Breaking News

What's working in mental health tech

Not rendering correctly? View this email as a web page here.
DD_Adobe_HCLS_Webinar_728x90px_A

Improving the patient financial experience requires an end to 'mafia'-style price negotiations

By Katie Adams Wednesday, September 28, 2022 7:13 PM

The patient financial experience in the U.S. is poor — patients have a hard time understanding pricing data and they often face exorbitant prices for care and medications. This problem will only get better if the healthcare industry rids itself of price-gouging middlemen and closed-door price negotiations held by businesspeople, according to a recent healthcare innovation panel.

Read more »

Eisai, Biogen beat expectations with data that support Alzheimer's drug approval

By Frank Vinluan Wednesday, September 28, 2022 2:12 PM

Eisai Alzheimer's disease drug candidate lecanemab now has data from a pivotal study showing a statistically significant reduction in cognitive decline. Lecanemab is already under FDA review for potential accelerated approval but the agency has said that results from this larger study could support full approval of the antibody drug.

Read more »

   

No comments